申请人:Ciba-Geigy Corporation
公开号:US03974284A1
公开(公告)日:1976-08-10
Compounds of the class of 1,1a,6,10b-tetrahydro-1,6-methano-dibenzo[a,e]cyclopropa[c]cycloheptene derivatives and their pharmaceutically acceptable acid addition salts have valuable pharmacological properties and are active ingredients for therapeutic compositions. In particular, these new compounds have an antidepressive and stimulating action. Specific embodiments are N-methyl-1,1a,6,10b-tetrahydro-1,6-methano-dibenzo[a,e]cyclopropa[c]cycloh eptene-11-amine-hydrochloride, N,N-dimethyl-1,1a,6,10b-tetrahydro-1,6-methano-dibenzo[a,e]cyclopropa[c]cy cloheptene-11-amine-fumarate,N-methyl-1,1a,6,10b-tetrahydro-1,6-methano-dib enzo[a,e]cyclopropa[c]cycloheptene-11-methylamine-maleate, N,N-dimethyl-1,1a,6,10b-tetrahydro-1,6-methano-dibenzo[a,e]cyclopropa[c]cy cloheptene-11-methylamine-hydrochloride,N,N-dimethyl-11-hydroxy-1,1a,6,10b- tetrahydro-1,6-methano-dibenzo[a,e]cyclopropa[c]cycloheptene-11-methylamine -fumarate and N,N-dimethyl-11-hydroxy-1,1a,6,10b-tetrahydro-1,6-methano-dibenzo[a,e]cycl opropa[c]cycloheptene-11-ethylamine-hydrochloride.
1,1a,6,10b-四氢-1,6-甲基-二苯并[a,e]环丙烷[c]环庚烯衍生物及其药学上可接受的酸盐化合物类具有重要的药理学特性,是治疗组合物的有效成分。特别地,这些新的化合物具有抗抑郁和兴奋作用。具体实施例包括N-甲基-1,1a,6,10b-四氢-1,6-甲基-二苯并[a,e]环丙烷[c]环庚烯-11-胺盐酸盐,N,N-二甲基-1,1a,6,10b-四氢-1,6-甲基-二苯并[a,e]环丙烷[c]环庚烯-11-胺富马酸盐,N-甲基-1,1a,6,10b-四氢-1,6-甲基-二苯并[a,e]环丙烷[c]环庚烯-11-甲基胺马来酸盐,N,N-二甲基-1,1a,6,10b-四氢-1,6-甲基-二苯并[a,e]环丙烷[c]环庚烯-11-甲基胺盐酸盐,N,N-二甲基-11-羟基-1,1a,6,10b-四氢-1,6-甲基-二苯并[a,e]环丙烷[c]环庚烯-11-甲基胺富马酸盐和N,N-二甲基-11-羟基-1,1a,6,10b-四氢-1,6-甲基-二苯并[a,e]环丙烷[c]环庚烯-11-乙基胺盐酸盐。